Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosisAngelo Sangiovanni, Pietro Lampertico, S. Maimone et al.|Journal of Hepatology|2020Cited by 57
Individual risk prediction of high grade prostate cancer based on the combination between total prostate-specific antigen (PSA) and free to total PSA ratioSimona Ferraro, Elia Biganzoli, Davide Biganzoli et al.|Clinical Chemistry and Laboratory Medicine (CCLM)|2023Cited by 32
Glut1 deficiency syndrome throughout life: clinical phenotypes, intelligence, life achievements and quality of life in familial casesSara Olivotto, Pierangelo Veggiotti, Alessandra Duse et al.|Orphanet Journal of Rare Diseases|2022Cited by 25
Reference intervals for thyroid biomarkers to enhance the assessment of thyroid status in childhood and adolescenceSimona Ferraro, Patrizia Boracchi, Ester Luconi et al.|Clinical Chemistry and Laboratory Medicine (CCLM)|2023Cited by 11
IFN-free DAA treatment of cirrhotic HCV patients with or without history of HCC: a multicenter prospective trial in ItalyAngelo Sangiovanni, Pietro Lampertico, Eleonora Alimenti et al.|Journal of Hepatology|2018Cited by 7